Amzell, B.V., a specialty pharmaceutical development company based in The Netherlands, and Amring Pharmaceuticals Inc. (Amring),…

Specialist development pharmaceutical company AMZELL B.V. and the FDA have reached an agreement on the protocol for the Phase 3 …

Specialist pharmaceutical development company Amzell B.V has acquired Bazell Pharma AG, a high-end clinical development and R&D …

The specialist pharmaceutical development company, Amzell BV has appointed Dr Alan Harris, as Chairman and former Chief Scientif…